For the ’whatisness’ of things is one of descriptions Land Institute founder Wes Jackson takes to heart, Tim Unruh writes.

Researchers used integrated Mendelian randomization in a cohort of over 247,000 individuals to identify 62 plasma proteins associated with breast cancer risk. Nine high-confidence targets, including ...

In his decades of leadership, Jackson introduced a “Prairiebilly” vocabulary that was hatched while growing up on Kansas ...

Ballard Partners will report $14 million in lobbying revenues for the first three months of 2025 — a huge surge in business.

In this article, we are going to take a look at where Lumen Technologies, Inc. (NYSE:LUMN) stands against other promising penny stocks. Solus’ Dan Greenhaus, and Invesco’s Brian Levitt togethe ...

Concerns about the future prospects for Lumen Technologies Inc. (NYSE: LUMN) have lingered. However, its fourth-quarter results suggested a positive shift in its financial health due to a focus on ...

JACKSON -- The Lumen Christi softball team scored 39 runs in a doubleheader sweep of Gabriel Richard on Tuesday, winning the first game 18-0 and the second 21-0. Erin O’Dowd had a triple and two ...

Bioscience Institute, a global leader in cutting-edge stem cell and regenerative medicine technologies, participated in the 2025 Dubai Derma Conference, which took place this week at the Dubai World ...

DF reviews the tech of Tempest Rising, a promising new RTS in the mould of Command and Conquer. How does this PC game run and with what UE5 features?

Survey of Neurocrine Biosciences’ Crenessity suggests strong uptake across all patient segments. Sales could reach ~$1B in 2030. Feel unsure about the market’s next move? Copy trade alerts ...

Caribou Biosciences, Inc. (NASDAQ:CRBU – Get Free Report) has been assigned a consensus recommendation of “Buy” from the five analysts that are covering the firm, MarketBeat reports.

Skye Bioscience's nimacimab, in Phase 2a trials, shows promise with significant weight loss results in mouse models, making it a speculative but potentially rewarding investment. 26-week results ...